Seeing Is Believing
Currently out of the existing stock ratings of Matt Hewitt, 121 are a BUY (83.45%), 23 are a HOLD (15.86%), 1 are a SELL (0.69%).
Analyst Matt Hewitt, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 45.02% that have a potential upside of 54.53% achieved within 271 days.
Matt Hewitt’s has documented 292 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on NEO, NeoGenomics at 20-Oct-2025.
Analyst best performing recommendations are on CDXS (CODEXIS).
The best stock recommendation documented was for SLP (SIMULATIONS PLUS) at 10/25/2021. The price target of $53 was fulfilled within 10 days with a profit of $12.07 (29.49%) receiving and performance score of 29.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Nov-2024
$12
$-0.49 (-3.92%)
$12
1 years 4 months 25 days ago
(07-Nov-2024)
10/14 (71.43%)
$-0.24 (-1.96%)
27
Buy Since 14-Mar-2023
$14
$1.51 (12.09%)
$14
1 years 6 months 2 days ago
(30-Sep-2024)
3/6 (50%)
$2.62 (23.02%)
126
Buy
$16
$7.76 (94.17%)
$22
2 years 3 months 23 days ago
(08-Dec-2023)
2/6 (33.33%)
$11.36 (244.83%)
266
Buy
$20
$11.76 (142.72%)
$22
2 years 9 months 9 days ago
(22-Jun-2023)
1/4 (25%)
$6.26 (45.56%)
92
Buy Since 17-Jul-2018
$9
$-3.49 (-27.94%)
$11
6 years 21 days ago
(11-Mar-2020)
3/3 (100%)
$4.49 (99.56%)
356
Which stock is Matt Hewitt is most bullish on?
What Year was the first public recommendation made by Matt Hewitt?